Search

Your search keyword '"Hellings, PW"' showing total 318 results

Search Constraints

Start Over You searched for: Author "Hellings, PW" Remove constraint Author: "Hellings, PW"
318 results on '"Hellings, PW"'

Search Results

1. Health-Related Quality of Life Impairment Among Patients with Severe Chronic Rhinosinusitis with Nasal Polyps in the SINUS-24 Trial

2. EUFOREA Comment on a Misleading Allergic Rhinitis Report [Letter]

3. Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis – A EUFOREA‐ARIA‐EPOS‐AIRWAYS ICP statement

4. Adherence to treatment in allergic rhinitis using mobile technology. the mask study

5. ARIA pharmacy 2018 'Allergic rhinitis care pathways for community pharmacy'

6. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

7. The effect of systemic treatments on periostin expression reflects their interference with the eosinophilic inflammation in chronic rhinosinusitis with nasal polyps

8. European position paper on diagnostic tools in rhinology

9. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study

11. ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

12. Transfer of innovation on allergic rhinitis and asthma multimorbidity in the elderly (MACVIA-ARIA) - Reference Site Twinning (EIP on AHA)

13. EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis

14. CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

15. Allergy immunotherapy across the life cycle to promote active and healthy ageing : from research to policies

16. Paving the future of rhinosinusitis care

17. What we should learn from the London Olympics

18. What we should learn from the London Olympics

19. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

21. What we should learn from the London Olympics

22. Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs

23. Severe Chronic Allergic (and related) Diseases: a uniform approach- a MeDALL- GA(2)LEN-ARIA Position Paper

26. Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis

27. Personal protection and delivery of rhinologic and endoscopic skull base procedures during the COVID-19 outbreak: ERS endorsed advises

28. Interleukin-5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils.

29. The nasal basal cell population shifts toward a diseased phenotype with impaired barrier formation capacity in allergic rhinitis.

30. Peak nasal inspiratory flow assessment of polyp size and response from SYNAPSE.

31. Dupilumab response onset, maintenance, and durability in patients with severe CRSwNP.

32. Rare presence and function of neuroendocrine cells in the nasal mucosa.

33. EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus.

34. EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP.

35. Nasal Obstruction: Overview of Pathophysiology and Presentation of a Clinically Relevant Preoperative Plan for Rhino(Septo)plasty.

36. Nasal hyperreactivity in allergic rhinitis and chronic rhinosinusitis with polyps: a role for neuronal pathways.

37. Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthma.

38. EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.

40. Nasal polyp syndrome: a patient-centred term for CRSwNP by EUFOREA.

41. Mitral valve replacement in children: balancing durability and risk with mechanical and bioprosthetic valves.

42. Reasons for rejection of rhinoplasty seeking patients: a multicentre observational study.

43. Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1-allergic asthma.

44. Sustained efficacy of mepolizumab in patients with severe chronic rhinosinusitis with nasal polyps: SYNAPSE 24-week treatment-free follow-up.

45. Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial.

46. Consensus criteria for chronic rhinosinusitis disease control: an international Delphi Study.

47. EUFOREA pocket guide on the diagnosis and management of asthma: An educational and practical tool for general practitioners, non-respiratory physicians, paramedics and patients.

48. Evaluation of skin prick location on the forearm using a novel skin prick automated test device.

49. The Management of Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) With Biologics.

50. Management paradigms for chronic rhinosinusitis in individuals with asthma: An evidence-based review with recommendations.

Catalog

Books, media, physical & digital resources